Peter J Wilkinson Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter J Wilkinson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter J Wilkinson. Peter J Wilkinson is SVP, Chief Accounting Officer in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and VP of Fin./Chief Acctg. Off. in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI).
Latest Insider Trading Transactions of Peter J Wilkinson
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | M | 182.51 | 633 | 115,529 | 1,267 | |
| Feb 19 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | M | 146.59 | 1,533 | 224,722 | 767 | |
| Feb 19 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 680 | 0 | 1,667 | |
| Feb 19 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 187 | 0 | 2,347 | |
| Feb 19 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Buy | M | 182.51 | 633 | 115,529 | 976 | 343 to 976 (+184.55 %) |
| Feb 19 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Sell | S | 241.52 | 2,317 | 559,589 | 343 | 2.7 K to 343 (-87.11 %) |
| Feb 19 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Buy | M | 146.59 | 1,533 | 224,722 | 2,660 | 1.1 K to 2.7 K (+136.02 %) |
| Feb 19 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Payment of Exercise | F | 238.26 | 201 | 47,890 | 1,127 | 1.3 K to 1.1 K (-15.14 %) |
| Feb 19 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Buy | M | 0.00 | 680 | 0 | 1,328 | 648 to 1.3 K (+104.94 %) |
| Feb 19 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Payment of Exercise | F | 238.26 | 62 | 14,772 | 648 | 710 to 648 (-8.73 %) |
| Feb 19 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Buy | M | 0.00 | 187 | 0 | 710 | 523 to 710 (+35.76 %) |
| Feb 08 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 150 | 0 | 2,534 | |
| Feb 08 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Payment of Exercise | F | 223.78 | 53 | 11,860 | 523 | 576 to 523 (-9.20 %) |
| Feb 08 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Buy | M | 0.00 | 150 | 0 | 576 | 426 to 576 (+35.21 %) |
| Feb 04 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | A | 233.39 | 1,200 | 280,068 | 1,200 | |
| Feb 04 2021 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | A | 0.00 | 350 | 0 | 2,684 | |
| Aug 18 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | A | 0.00 | 150 | 0 | 2,334 | |
| Feb 25 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Sell | S | 189.65 | 297 | 56,326 | 297 | 594 to 297 (-50.00 %) |
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 680 | 0 | 2,184 | |
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 186 | 0 | 2,864 | |
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Payment of Exercise | F | 187.51 | 206 | 38,627 | 594 | 800 to 594 (-25.75 %) |
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Buy | M | 0.00 | 680 | 0 | 800 | 120 to 800 (+566.67 %) |
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Payment of Exercise | F | 187.51 | 66 | 12,376 | 120 | 186 to 120 (-35.48 %) |
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Buy | M | 0.00 | 186 | 0 | 186 | 0 to 186 |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | A | 182.51 | 1,900 | 346,769 | 1,900 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | A | 0.00 | 450 | 0 | 3,050 | |
| Oct 03 2008 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Option Exercise | A | 39.01 | 4,000 | 156,040 | 4,000 | |
| Jul 08 2008 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Buy | I | 36.33 | 241 | 8,756 | 474 | 233 to 474 (+103.43 %) |
| Feb 22 2008 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Option Exercise | A | 44.78 | 6,065 | 271,591 | 6,065 | |
| Jan 04 2008 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Buy | I | 34.44 | 233 | 8,025 | 233 | 0 to 233 |
| Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Option Exercise | M | 13.00 | 6,000 | 78,000 | 0 | |
| Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.08 | 76 | 3,198 | 0 | 76 to 0 (-100.00 %) |
| Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.07 | 100 | 4,207 | 76 | 176 to 76 (-56.82 %) |
| Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.06 | 1,100 | 46,266 | 176 | 1.3 K to 176 (-86.21 %) |
| Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.04 | 100 | 4,204 | 1,276 | 1.4 K to 1.3 K (-7.27 %) |
| Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.02 | 100 | 4,202 | 1,376 | 1.5 K to 1.4 K (-6.78 %) |
| Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.01 | 1,455 | 61,125 | 1,476 | 2.9 K to 1.5 K (-49.64 %) |
| Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.05 | 3,069 | 129,051 | 2,931 | 6 K to 2.9 K (-51.15 %) |
| Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Buy | M | 13.00 | 6,000 | 78,000 | 6,000 | 0 to 6 K |
| Aug 17 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 36.79 | 318 | 11,699 | 0 | 318 to 0 (-100.00 %) |
| Aug 17 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 36.74 | 395 | 14,512 | 318 | 713 to 318 (-55.40 %) |
| Aug 17 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 36.73 | 574 | 21,083 | 713 | 1.3 K to 713 (-44.60 %) |
| Jul 05 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Buy | I | 29.00 | 199 | 5,771 | 1,286 | 1.1 K to 1.3 K (+18.31 %) |
| May 17 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Option Exercise | A | 33.82 | 15,000 | 507,300 | 15,000 |
Page: 1